Deletion of the AD risk gene, triggering receptor expressed on myeloid cells 2 (TREM2), similarly decreased the initial deposition of amyloid but conversely promotes amyloid deposition at later ages (Jay et al., 2017). Here, TREM2 is linked to Alzheimer disease.